JBR Journal of Clinical Diagnosis and Research
黑料网
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
Useful Links
Recommended Journals
Related Subjects
Share This Page
Cameron Yin C
Cameron Yin C
Associate Professor
Department of Hematopathology
The University of Texas
USA
Biography
Dr. C. Cameron Yin, MD, PhD, is an associate professor in the Department of Hematopathology at the University of Texas MD Anderson Cancer Center and UT Graduate School of Biomedical Sciences. She is board certified by the American Board of Pathology in Anatomic Pathology, Clinical Pathology, Hematology and Molecular Genetic Pathology. In addition to clinical responsibilities on the Leukemia, Lymphoma and Molecular Diagnostic Laboratory services, Dr. Yin has been actively participating in multiple research projects in leukemia and lymphoma, which has led to over 80 research papers and over 20 book chapters. She serves as members of editorial boards for 20 journals and ad hoc reviewers for 30 journals. Her major research interests include study of mechanisms of resistance to tyrosine kinase inhibitors in patients with chronic myelogenous leukemia, development of molecular methodologies to monitor minimal residual diseases, as well as study of molecular genetic aberrations in leukemia and lymphoma.
Research Interest
"Mechanisms of imatinib resistance in patients with chronic myelogenous leukemia Molecular monitoring of responses to kinase inhibitors in chronic myelogenous leukemia Immunoglobulin gene rearrangement in acute myeloid leukemia Clinical, morphologic and molecular genetic features of leukemias and lymphomas Molecular markers as a tool in the diagnosis, targeted therapy and prognosis in cancer"
Certificate
